Akancha Singh is a dedicated professional in the field of Regulatory Affairs with a focus on Quality and Regulatory Compliance. With a Master of Science degree from Northeastern University, Akancha brings a wealth of knowledge and expertise to the advanced therapies industry. She has a proven track record of ensuring compliance with regulatory requirements and implementing quality systems to support the development and commercialization of cutting-edge therapies.
Akancha's passion for advancing healthcare through innovative therapies is evident in her work. She is committed to staying abreast of the latest regulatory developments and leveraging her expertise to navigate complex regulatory landscapes. Her attention to detail, analytical skills, and strategic mindset make her a valuable asset in ensuring the successful development and approval of advanced therapies.
With a strong background in regulatory affairs and quality management, Akancha has a deep understanding of the regulatory processes involved in bringing advanced therapies to market. Her ability to collaborate cross-functionally and communicate effectively with regulatory agencies sets her apart as a trusted expert in the field.
At Advanced Therapies USA 2025, Akancha will share her insights and experiences in Advanced Therapies USA 2025 Congress taking place on November 18-19, 2025, in Philadelphia, Pennsylvania Convention Center, navigating the evolving regulatory environment for advanced therapies. Attendees can expect to gain valuable knowledge and practical strategies for achieving regulatory compliance and driving successful outcomes in this rapidly evolving industry.